About us
Meet the team behind Abacus Medicine CTS and learn more about the Abacus Medicine Group.
Who is Abacus Medicine?
Abacus Medicine was founded in 2004 by CEO Flemming Wagner and his father John Wagner (1932-2018). Since then, Abacus Medicine has grown continuously and has established itself among the market leaders in the European parallel trade industry.
Abacus Medicine represents the parallel trade-branch of the Abacus Medicine Group. Abacus Medicine and our parallel trade-business remains the largest contributor to our financial results and continuous growth.
If you are looking for career opportunities, financial information and corporate news, visit the Abacus Medicine Group’s website.
The history of Abacus Medicine
Abacus Medicine was founded on the basis of a growing call for competition in the Danish pharmaceutical market to the benefit of Danish hospitals. To answer this call, Flemming and John Wagner founded Abacus Medicine with the purpose of carrying out parallel import and parallel distribution of original medicine within the EU.
Not long after it was founded, Abacus Medicine entered the Danish pharmaceutical market. Following this successful entrance, the company expanded its reach to Germany and Sweden. Since then, Abacus Medicine has pursued a vigorous and highly successful multi-market strategy, and our parallel import services are now available in 12 European markets with more to come.
Apart from our many active sales markets, we also have sales offices in 6 European countries: Denmark, the Netherlands, Germany, Austria, Spain and United Kingdom. Our office in Copenhagen, Denmark functions as our headquarters for both the Group and Abacus Medicine.
Our team
Karan Gulati
Martin Harper
Ian Hoban
Lucy Fox
Phillip Ashton
Pranita More
Claire Smith
William Van
Tiffany Chan
Shania Shan Poon
Sharon Leung
Nikolas Bauditz
Pinkesh Shah
Krista Winkler
Mari Blasi
Simona Semprebene
Nicolas Martens Villasmil
Aurelia Ventriglia
Ready to take the next step?
Let us share how we could successfully support your clinical trials.